These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of contrast material for spiral CT of the abdomen: comparison of hepatic enhancement and vascular attenuation for three different contrast media at two different delay times. Herts BR; Paushter DM; Einstein DM; Zepp R; Friedman RA; Obuchowski N AJR Am J Roentgenol; 1995 Feb; 164(2):327-31. PubMed ID: 7839963 [TBL] [Abstract][Full Text] [Related]
3. Effects of injection rates of contrast material on arterial phase hepatic CT. Kim T; Murakami T; Takahashi S; Tsuda K; Tomoda K; Narumi Y; Oi H; Nakamura H AJR Am J Roentgenol; 1998 Aug; 171(2):429-32. PubMed ID: 9694469 [TBL] [Abstract][Full Text] [Related]
4. Time-course characterization of the computed tomography contrast enhancement of an iodinated blood-pool contrast agent in mice using a volumetric flat-panel equipped computed tomography scanner. Ford NL; Graham KC; Groom AC; Macdonald IC; Chambers AF; Holdsworth DW Invest Radiol; 2006 Apr; 41(4):384-90. PubMed ID: 16523021 [TBL] [Abstract][Full Text] [Related]
5. Contrast media in abdominal computed tomography: optimization of delivery methods. Han JK; Choi BI; Kim AY; Kim SJ Korean J Radiol; 2001; 2(1):28-36. PubMed ID: 11752966 [TBL] [Abstract][Full Text] [Related]
6. Computed tomography contrast enhancement principles and the use of high-concentration contrast media. Herman S J Comput Assist Tomogr; 2004; 28 Suppl 1():S7-11. PubMed ID: 15258487 [TBL] [Abstract][Full Text] [Related]
7. CT arterial portography of the abdomen: effect of injecting papaverine into the mesenteric artery on hepatic contrast enhancement. Soyer P; Lacheheb D; Levesque M AJR Am J Roentgenol; 1993 Jun; 160(6):1213-5. PubMed ID: 8498218 [TBL] [Abstract][Full Text] [Related]
8. Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material. Ichikawa T; Erturk SM; Araki T Eur J Radiol; 2006 May; 58(2):165-76. PubMed ID: 16417983 [TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced spiral CT of the liver: effect of different amounts and injection rates of contrast material on early contrast enhancement. Small WC; Nelson RC; Bernardino ME; Brummer LT AJR Am J Roentgenol; 1994 Jul; 163(1):87-92. PubMed ID: 8010255 [TBL] [Abstract][Full Text] [Related]
10. Factors influencing vascular and hepatic enhancement at CT: experimental study on injection protocol using a canine model. Han JK; Kim AY; Lee KY; Seo JB; Kim TK; Choi BI; Lhee CS; Han MC J Comput Assist Tomogr; 2000; 24(3):400-6. PubMed ID: 10864075 [TBL] [Abstract][Full Text] [Related]
11. Hepatic spiral CT: reduction of dose of intravenous contrast material. Brink JA; Heiken JP; Forman HP; Sagel SS; Molina PL; Brown PC Radiology; 1995 Oct; 197(1):83-8. PubMed ID: 7568859 [TBL] [Abstract][Full Text] [Related]
12. Hepatic helical CT: effect of reduction of iodine dose of intravenous contrast material on hepatic contrast enhancement. Freeny PC; Gardner JC; vonIngersleben G; Heyano S; Nghiem HV; Winter TC Radiology; 1995 Oct; 197(1):89-93. PubMed ID: 7568860 [TBL] [Abstract][Full Text] [Related]
13. Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Bae KT Radiology; 2010 Jul; 256(1):32-61. PubMed ID: 20574084 [TBL] [Abstract][Full Text] [Related]
14. [Spiral-CT of the liver: optimizing contrast medium administration and examination technique]. Vogl TJ; Hidajat N; Schröder RJ; Pegios W; Langer R; Neuhaus P; Felix R Aktuelle Radiol; 1996 Jan; 6(1):7-12. PubMed ID: 8852767 [TBL] [Abstract][Full Text] [Related]
15. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695 [TBL] [Abstract][Full Text] [Related]
16. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate--pharmacokinetic analysis and experimental porcine model. Bae KT; Heiken JP; Brink JA Radiology; 1998 Feb; 206(2):455-64. PubMed ID: 9457200 [TBL] [Abstract][Full Text] [Related]
17. Hepatic contrast enhancement at CT: influence of intravenous glucagon in a canine model. Warshauer DM; Hiken JN; Molina PL; Hackney SL; Bellinger DA; Lee JK Radiology; 1995 Nov; 197(2):365-8. PubMed ID: 7480678 [TBL] [Abstract][Full Text] [Related]
18. Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients. Chambers TP; Baron RL; Lush RM Radiology; 1994 Nov; 193(2):513-7. PubMed ID: 7972770 [TBL] [Abstract][Full Text] [Related]
20. Optimal vascular and parenchymal contrast enhancement: the current state of the art. Fleischmann D; Kamaya A Radiol Clin North Am; 2009 Jan; 47(1):13-26. PubMed ID: 19195531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]